BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17673260)

  • 1. WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat.
    Vera G; Chiarlone A; Cabezos PA; Pascual D; Martín MI; Abalo R
    Life Sci; 2007 Jul; 81(6):468-79. PubMed ID: 17673260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat.
    Abalo R; Cabezos PA; Vera G; López-Pérez AE; Martín MI
    Neurogastroenterol Motil; 2013 May; 25(5):373-82, e292. PubMed ID: 23594243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered feeding behaviour induced by long-term cisplatin in rats.
    Vera G; Chiarlone A; Martín MI; Abalo R
    Auton Neurosci; 2006 Jun; 126-127():81-92. PubMed ID: 16567130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica.
    Cabezos PA; Vera G; Martín-Fontelles MI; Fernández-Pujol R; Abalo R
    Neurogastroenterol Motil; 2010 Jul; 22(7):797-805, e224-5. PubMed ID: 20236245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.
    Burgos E; Gómez-Nicola D; Pascual D; Martín MI; Nieto-Sampedro M; Goicoechea C
    Eur J Pharmacol; 2012 May; 682(1-3):62-72. PubMed ID: 22374260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats.
    Pascual D; Goicoechea C; Suardíaz M; Martín MI
    Pain; 2005 Nov; 118(1-2):23-34. PubMed ID: 16213089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
    Radziszewska E; Bojanowska E
    Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat.
    Abalo R; Cabezos PA; López-Miranda V; Vera G; González C; Castillo M; Fernández-Pujol R; Martín MI
    Neurogastroenterol Motil; 2009 Sep; 21(9):1002-e80. PubMed ID: 19413685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat.
    De Jonghe BC; Horn CC
    Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R756-65. PubMed ID: 18184757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the Cannabinoid Agonist WIN 55,212-2 on Neuropathic and Visceral Pain Induced by a Non-Diarrheagenic Dose of the Antitumoral Drug 5-Fluorouracil in the Rat.
    Vera G; López-Gómez L; Girón R; Martín-Fontelles MI; Nurgali K; Abalo R; Uranga JA
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats.
    Ulugol A; Karadag HC; Ipci Y; Tamer M; Dokmeci I
    Neurosci Lett; 2004 Nov; 371(2-3):167-70. PubMed ID: 15519750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
    Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
    Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic pain.
    Guindon J; Desroches J; Dani M; Beaulieu P
    Eur J Pharmacol; 2007 Jul; 568(1-3):173-6. PubMed ID: 17555742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy.
    Vera G; Cabezos PA; Martín MI; Abalo R
    Pharmacol Biochem Behav; 2013 Apr; 105():205-12. PubMed ID: 23454533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of styrene maleic acid WIN55,212-2 micelles on neuropathic pain in a rat model.
    Linsell O; Brownjohn PW; Nehoff H; Greish K; Ashton JC
    J Drug Target; 2015 May; 23(4):353-9. PubMed ID: 25541465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
    Burgos E; Pascual D; Martín MI; Goicoechea C
    Eur J Pain; 2010 Jan; 14(1):40-8. PubMed ID: 19318283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats.
    Li J; Daughters RS; Bullis C; Bengiamin R; Stucky MW; Brennan J; Simone DA
    Pain; 1999 May; 81(1-2):25-33. PubMed ID: 10353490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes.
    Vera G; López-Miranda V; Herradón E; Martín MI; Abalo R
    Pharmacol Biochem Behav; 2012 Aug; 102(2):335-43. PubMed ID: 22609797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats.
    Lim G; Sung B; Ji RR; Mao J
    Pain; 2003 Sep; 105(1-2):275-83. PubMed ID: 14499445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats.
    Mehendale S; Aung H; Wang A; Yin JJ; Wang CZ; Xie JT; Yuan CS
    Cancer Chemother Pharmacol; 2005 Jul; 56(1):63-9. PubMed ID: 15791456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.